Nanobiotechnology are increasingly used in a variety of industries, from medicine and electronics to cosmetics and textiles. However, their unique properties also bring potential risks to humans, animals, and the environment. As such, assessing the risks associated with Nanobiotechnology is an important step in their safe and effective use. Risk assessment of Nanobiotechnology involves evaluating both their potential benefits and potential hazards. The process typically begins with an initial assessment that takes into account the characteristics of the nanomaterial and its intended use. The assessment then moves on to consider the potential risks associated with each use. This involves examining the nanomaterial’s toxicity, the potential for exposure, and other factors such as the human and environmental fate of the material. The next step in the risk assessment process is to identify any potential risk mitigation strategies. These can include identifying substitutes with lower risk, using various containment systems, or developing more effective methods of disposal. All of these strategies must be carefully evaluated to ensure that they reduce the risk of harm to humans, animals, and the environment. Finally, the risk assessment process should consider the rate at which new data and information become available.
Health and safety experts face an ongoing challenge in evaluating the risks linked to the increasing utilization of engineered nanomaterials (ENM) in research. Given the constantly changing…
Participants can earn 1 CPD credit for each hour of attendance.
Oral and poster slots for original Risk Assessment work, reviewed by the scientific committee.
Meet nanotechnologists, researchers, scientists and engineers from around the world across three days.
In-person and virtual registrations include an electronic copy of the abstract book.
Plenary lectures from leading voices shaping Risk Assessment research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Risk Assessment track is a dedicated stream within World Nano 2027 covering the latest research, innovation, and best practice in Risk Assessment. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Nanotechnology researchers, scientists and engineers, educators and students with an interest in Risk Assessment are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Yes. World Nano 2027 is a hybrid conference — attend the Risk Assessment track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.
